| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7105207ca740add5aa1300e0c7f20a8a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
| filingDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007f85d580d52ffc45db21d0af50f0b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2699b4778d93fcdeaed932b31325ed54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96691d821d2959733d88e4ad0612b2f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81fe89123884a05b3102cde95731fc9b |
| publicationDate |
2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3328868-A1 |
| titleOfInvention |
Cyclic diarylboron derivatives as nlrp3 inflammasome inhibitors |
| abstract |
Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed. |
| priorityDate |
2015-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |